Recruiting

Observational Study

Sponsor:

Arkansas Children's Hospital Research Institute

Code:

NCT00632112

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Continuous albuterol has become the standard of care for patients in status asthmaticus. We have previously performed an in-vitro study comparing 4 different brands of continuous nebulizers. We now want to compare the in-vitro with the in-vivo performance of the brand we use. we hypothesize that there will be no difference between in-vivo and in-vitro results.

Conditions

Asthma

Study ID

NCT00632112

Start date

Mar, 2008

Status verified date

Jun, 2009

Primary completion date

Jul, 2009

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Pediatric patients admitted to Pediatric Intensive Care Unit due to status asthmaticus, requiring continuous albuterol nebulization.

Exclusion Criteria:

  • Patients requiring invasive or non-invasive ventilation.

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Nebulizer solution output [ Time Frame: every 2 hours for first 6 hours ]

Central Contacts and Locations

Central contacts

Ariel Berlinski, M.D.

501-364-1006berlinskiariel@uams.edu

Locations

Arkansas Children's Hospital

Recruiting

Little Rock, Arkansas, United States, 72202

Contacts

Ariel Berlinski, M.D.

501-364-1006berlinskiariel@uams.edu

Principal Investigator:

Ariel Berlinski, M.D.

More Information

Sponsor

Arkansas Children's Hospital Research Institute

Last update posted

Jun 5, 2009

Last verified

Jun, 2009

Keywords

  • large volume nebulizer

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Arkansas Children's Hospital Research Institute on 2009-06-05.